Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bert E Thomas

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Medicinal Research Reviews|October 9, 2002
Design and synthesis of sialyl Lewis(x) mimics as E- and P-selectin inhibitorsNeelu Kaila, Bert E Thomas
Proteins|March 28, 2003
Pharmacophore-based molecular docking to account for ligand flexibilityDiane Joseph-McCarthy, Bert E Thomas, Michael Belmarsh, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 25, 2019
A Global Phase I Clinical Study Comparing the Safety and Pharmacokinetics of Proposed Biosimilar BAT1706 and Bevacizumab (Avastin<sup>®</sup>) in Healthy Male SubjectsXiaoyun Wu, Chris Wynne, Chenchao Xu, et al.
Journal of Medicinal Chemistry|April 5, 2002
Beta-C-mannosides as selectin inhibitorsNeelu Kaila, Lihren Chen, Bert E Thomas, et al.
Bioorganic & Medicinal Chemistry Letters|October 14, 2003
Synthesis and evaluation of chiral bicyclic proline FKBP12 ligandsDavid C Limburg, Bert E Thomas, Jia-He Li, et al.
Journal of Medicinal Chemistry|March 21, 2003
Synthesis and biological evaluation of non-peptidic cyclophilin ligandsYong-Qian Wu, Sergei Belyakov, Chi Choi, et al.
Bioorganic & Medicinal Chemistry|October 15, 2003
Synthesis, molecular modeling and biological evaluation of aza-proline and aza-pipecolic derivatives as FKBP12 ligands and their in vivo neuroprotective effectsDouglas E Wilkinson, Bert E Thomas, David C Limburg, et al.
Journal of Medicinal Chemistry|June 25, 2005
Quinic acid derivatives as sialyl Lewis(x)-mimicking selectin inhibitors: design, synthesis, and crystal structure in complex with E-selectinNeelu Kaila, William S Somers, Bert E Thomas, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Medicinal Research Reviews|October 9, 2002
Design and synthesis of sialyl Lewis(x) mimics as E- and P-selectin inhibitorsNeelu Kaila, Bert E Thomas
Proteins|March 28, 2003
Pharmacophore-based molecular docking to account for ligand flexibilityDiane Joseph-McCarthy, Bert E Thomas, Michael Belmarsh, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 25, 2019
A Global Phase I Clinical Study Comparing the Safety and Pharmacokinetics of Proposed Biosimilar BAT1706 and Bevacizumab (Avastin<sup>®</sup>) in Healthy Male SubjectsXiaoyun Wu, Chris Wynne, Chenchao Xu, et al.
Journal of Medicinal Chemistry|April 5, 2002
Beta-C-mannosides as selectin inhibitorsNeelu Kaila, Lihren Chen, Bert E Thomas, et al.
Bioorganic & Medicinal Chemistry Letters|October 14, 2003
Synthesis and evaluation of chiral bicyclic proline FKBP12 ligandsDavid C Limburg, Bert E Thomas, Jia-He Li, et al.
Journal of Medicinal Chemistry|March 21, 2003
Synthesis and biological evaluation of non-peptidic cyclophilin ligandsYong-Qian Wu, Sergei Belyakov, Chi Choi, et al.
Bioorganic & Medicinal Chemistry|October 15, 2003
Synthesis, molecular modeling and biological evaluation of aza-proline and aza-pipecolic derivatives as FKBP12 ligands and their in vivo neuroprotective effectsDouglas E Wilkinson, Bert E Thomas, David C Limburg, et al.
Journal of Medicinal Chemistry|June 25, 2005
Quinic acid derivatives as sialyl Lewis(x)-mimicking selectin inhibitors: design, synthesis, and crystal structure in complex with E-selectinNeelu Kaila, William S Somers, Bert E Thomas, et al.
Pageof 1